Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.
作者信息
Zaragoza Rafael, Pemán Javier, Quindós Guillermo, Iruretagoyena Jose R, Cuétara María S, Ramírez Paula, Gómez Maria D, Camarena Juan J, Viudes Angel, Pontón José
机构信息
Intensive Care Unit and Department of Microbiology, Valencia, Spain.
出版信息
Clin Vaccine Immunol. 2009 Oct;16(10):1527-8. doi: 10.1128/CVI.00183-09. Epub 2009 Aug 12.
Abstract
The influence of kinetic patterns of Candida albicans germ tube antibodies (CAGTA) on mortality was analyzed in six intensive care units. Statistically significant lower mortality rates were found in patients with patterns of increasing CAGTA titers who had been treated with antifungal agents. Thus, antifungal treatment should be considered when CAGTA titers are increasing in critically ill patients.
摘要
相似文献
1
Kinetic patterns of Candida albicans germ tube antibody in critically ill patients: influence on mortality.
Clin Vaccine Immunol. 2009 Oct;16(10):1527-8. doi: 10.1128/CVI.00183-09. Epub 2009 Aug 12.
2
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
BMC Infect Dis. 2011 Mar 9;11:60. doi: 10.1186/1471-2334-11-60.
3
Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.
J Microbiol Immunol Infect. 2020 Oct;53(5):778-784. doi: 10.1016/j.jmii.2019.02.001. Epub 2019 Mar 11.
4
Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.
Mycopathologia. 2017 Aug;182(7-8):645-652. doi: 10.1007/s11046-017-0125-9. Epub 2017 Apr 4.
5
Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.
Clin Microbiol Infect. 2009 Jun;15(6):592-5. doi: 10.1111/j.1469-0691.2009.02794.x. Epub 2009 May 11.
6
Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
Crit Care. 2016 May 16;20(1):149. doi: 10.1186/s13054-016-1324-3.
7
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2.
8
Detection of anti-Candida antibodies in neonates from a Neonatal Intensive Care Unit.
Folia Microbiol (Praha). 2002;47(3):297-301. doi: 10.1007/BF02817656.
9
Detection of antibodies to Candida albicans germ tube as a possible aid in diagnosing systemic candidiasis in bone marrow transplant patients.
Eur J Clin Microbiol Infect Dis. 1993 May;12(5):347-9. doi: 10.1007/BF01964431.
10
Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
Diagn Microbiol Infect Dis. 2019 Jan;93(1):39-43. doi: 10.1016/j.diagmicrobio.2018.07.007. Epub 2018 Aug 8.
引用本文的文献
1
Anti-Candida Antibodies of Patients with Invasive Candidiasis Inhibit Growth, Alter Cell Wall Structure, and Kill Candida albicans In Vitro.
Mycopathologia. 2024 Feb 7;189(1):16. doi: 10.1007/s11046-023-00819-w.
2
Biomarkers of fungal infection: Expert opinion on the current situation.
Rev Esp Quimioter. 2020 Feb;33(1):1-10. doi: 10.37201/req/2260.2019. Epub 2019 Nov 14.
3
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors.
Infection. 2016 Apr;44(2):223-33. doi: 10.1007/s15010-015-0849-8. Epub 2015 Oct 16.
4
β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
Intensive Care Med. 2015 Aug;41(8):1424-32. doi: 10.1007/s00134-015-3922-y. Epub 2015 Jul 2.
5
Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
BMC Infect Dis. 2011 Mar 9;11:60. doi: 10.1186/1471-2334-11-60.
本文引用的文献
1
Clinical significance of the detection of Candida albicans germ tube-specific antibodies in critically ill patients.
Clin Microbiol Infect. 2009 Jun;15(6):592-5. doi: 10.1111/j.1469-0691.2009.02794.x. Epub 2009 May 11.
2
Invasive fungal infections in critically ill patients: different therapeutic options and a uniform strategy.
Rev Iberoam Micol. 2006 Jun;23(2):59-63. doi: 10.1016/s1130-1406(06)70014-6.
3
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Clin Infect Dis. 2006 Jul 1;43(1):25-31. doi: 10.1086/504810. Epub 2006 May 16.
4
Clinical review: role of triggering receptor expressed on myeloid cells-1 during sepsis.
Crit Care. 2005 Oct 5;9(5):485-9. doi: 10.1186/cc3732. Epub 2005 Jun 3.
5
Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality.
Antimicrob Agents Chemother. 2005 Sep;49(9):3640-5. doi: 10.1128/AAC.49.9.3640-3645.2005.
6
Antibodies to Candida albicans germ tubes in two intensive care patients with invasive candidiasis.
Rev Iberoam Micol. 2000 Sep;17(3):93-6.
7
Specific antibody response in a patient with Candida dubliniensis fungemia.
Rev Iberoam Micol. 2001 Mar;18(1):42-4.
8
Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis.
Med Mycol. 2004 Aug;42(4):319-24. doi: 10.1080/13693780310001644653.
9
Is there a role for antibody testing in the diagnosis of invasive candidiasis?
Rev Iberoam Micol. 2004 Mar;21(1):10-4.
10
[Evaluation of a new commercial test (Candida albicans IFA IgG) for the serodiagnosis of invasive candidiasis].
Enferm Infecc Microbiol Clin. 2004 Feb;22(2):83-8. doi: 10.1016/s0213-005x(04)73039-6.
Zotero 插件